SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-018928
Filing Date
2022-01-27
Accepted
2022-01-27 06:15:03
Documents
16
Period of Report
2022-01-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d286358d8k.htm   iXBRL 8-K 33304
2 EX-1.1 d286358dex11.htm EX-1.1 241844
3 EX-4.1 d286358dex41.htm EX-4.1 58510
4 EX-5.1 d286358dex51.htm EX-5.1 11533
8 GRAPHIC g286358snap2.jpg GRAPHIC 4352
  Complete submission text file 0001193125-22-018928.txt   558943

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA srra-20220126.xsd EX-101.SCH 2866
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20220126_lab.xml EX-101.LAB 17236
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20220126_pre.xml EX-101.PRE 10819
10 EXTRACTED XBRL INSTANCE DOCUMENT d286358d8k_htm.xml XML 3216
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37490 | Film No.: 22559792
SIC: 2834 Pharmaceutical Preparations